GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 28 weeks on 10mg, full numbers, ask me anything boring — 46 comments in the full submission. View in context.
2.6k
c/survodutide·submitted 11 months ago by u/thermal_mass_tom

[Results] 28 weeks on 10mg, full numbers, ask me anything boring

Trial Databranch of 9 comments

28 weeks on 10mg, full numbers, ask me anything boring. This is a description of what happened to me and not a plan for anybody else. Numbers, in the order they matter: 28 weeks and 10mg. Phase 2 in a biopsy-confirmed population is a demanding design: recruitment is slow, the population is specific, and the results…

Read the full submission and all 46 comments →

This branch

9 comments, started 11 months ago
u/border_paperwork124 points·11 months ago

How fast was the escalation in that protocol?

replysharereportpermalink
u/liv_vukovic103 points·11 months ago

Biopsy-confirmed population or imaging-selected?

replysharereportpermalink
u/patient_labslip_log138 points·11 months ago

Which phase and which arm are you quoting?

replysharereportpermalink
u/sofia_ferreira100 points·11 months ago

Which phase and which arm are you quoting?

This is the framing the board needs. It is a hepatic programme first.

replysharereportpermalink
u/thermal_mass_tomOP77 points·11 months ago

Small fix — dual agonist, GLP-1 and glucagon. No GIP arm in this molecule.

replysharereportpermalink
[removed]36 points·11 months ago

[removed by moderator]

replysharereportpermalink
u/tomas_lokken28 points·11 months ago

independent testing on this compound is very thin

replysharereportpermalink
u/preservative_free_p98 points·11 months ago

research material is not approved for human use, which is why the clinical record here is thin

replysharereportpermalink
u/zeynep_villalobos56 points·11 months ago

Agreed that the endpoint definitions matter enormously and almost nobody reads them before quoting a response rate.

replysharereportpermalink

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/survodutide
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/liver_enzyme_lizu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →